Hepatitis C is a lesser-known virus that significantly impacts liver health and can lead to Cirrhosis, especially here in Mauritius. This virus is commonly spread through blood and bodily fluids, making it more prevalent among individuals who engage in intravenous drug use (PWID). Often, primary infections show no symptoms, leaving patients unaware until Cirrhosis symptoms develop. Detecting the infection early is crucial, as treatment at this stage is highly effective with minimal side effects, allowing patients to lead normal lives post-cure.

To meet WHO's targets for Hepatitis C Elimination by 2030, we've collaborated closely with various stakeholders, including AIDS unit doctors and Harm Reduction Units, to reach as many affected individuals as possible. Additionally, we've decentralized our services, working with NGOs to provide screenings, phlebotomy services, and even dispense Hepatitis C medications at their sites. Notably, we've achieved micro-elimination of Hepatitis C in prisons across Mauritius by making treatment readily available. Our latest initiative involves visiting Methadone Dispensing Sites to screen and link patients to care, marking a significant step towards national Hepatitis C elimination. Through these efforts, we aim to ensure that every individual affected by Hepatitis C receives the necessary care and support for a healthier future.